COULD AMNOG BECOME IRRELEVANT IN THE 21ST CENTURY? POTENTIAL REDUNDANCIES IN THE AMNOG PROCESS IN THE ERA OF CURATIVE THERAPIES
Author(s)
Macaulay R
Parexel Access Consulting, London, UK
Presentation Documents
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PHP353
Topic
Health Policy & Regulatory
Disease
Multiple Diseases
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now